Skip to content
Lower risk Medical device recall · FDA · Published March 19, 2018

Teleflex Medical LMA MADgic Laryngotracheal Mucosal Atomization Device Recall: Missing

Teleflex Medical recalls MAD700 laryngotracheal mucosal atomization device due to potential missing or incomplete package label information. Affected units may not have proper labeling for topical anesthetic use.

🇺🇸 FDA recall #Z-1628-2018Medical deviceTeleflex Medical ›
Take action

Contact the company

Recalling firmTeleflex Medical Europe LtdIda Business Park · Athlone, Ireland
✎ GovInfoNow plain-language explainer

What happened, in plain English

Teleflex Medical is recalling their MAD700 laryngotracheal mucosal atomization device because the package label might be missing or incomplete. This could affect safe use for topical anesthetic applications in the oropharynx and upper airway. Read more at govinfonow.com/recall/71682-teleflex-medical-lma-madgic-laryngotracheal-mucosal-atomization-device-recall-missing.

Source Summary by GovInfoNow · govinfonow.com/recall/71682-teleflex-medical-lma-madgic-laryngotracheal-mucosal-atomization-device-recall-missing · Updated August 27, 2026 · FDA enforcement record: FDA #Z-1628-2018

Cite this page

“Teleflex Medical LMA MADgic Laryngotracheal Mucosal Atomization Device Recall: Missing.” GovInfoNow, updated August 27, 2026. https://govinfonow.com/recall/71682-teleflex-medical-lma-madgic-laryngotracheal-mucosal-atomization-device-recall-missing. Based on FDA recall #Z-1628-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1628-2018%22&limit=1).

Why it’s dangerous

The device may have missing or incomplete information on the package label. This could lead to improper use if the user cannot verify the correct labeling for topical anesthetic applications. However, the hazard does not involve physical risks like injury or malfunction.

Who’s affected

Healthcare professionals using the device for topical anesthetic applications in the oropharynx and upper airway are most likely affected. The risk is low as the hazard involves labeling information rather than physical safety issues.

How to tell if you have this one

Check for the product name 'Teleflex MEDICAL LMA(TM) MADgic(TM) Laryngotracheal Mucosal Atomization Device, MAD700' with lot number 161212. The device is intended for topical anesthetic use in the oropharynx and upper airway.

  • Brand
    Teleflex Medical
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Package Label

    Verify that the package label contains complete information for topical anesthetic use in the oropharynx and upper airway.

Where it went and when

Where it was distributed

Distributed in Texas.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: not listedFL

FDA distribution: “TX” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Texas.

Recall timeline

FDA terminated this recall 17 months after the firm started it.

1. Firm started the recall: Mar 19, 201812. FDA classified it Class II: May 3, 201823. Published in FDA’s Enforcement Report: May 9, 201834. FDA terminated the recall: Aug 27, 2019420182019
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1628-2018 (March 19, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1628-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on August 27, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA